Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04695782 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pencil Beam Proton Therapy for Pelvic Recurrences in Rectal Cancer Patients Previously Treated With Radiotherapy

Name: Pencil Beam Proton Therapy for Pelvic Recurrences in Rectal Cancer Patients Previously Treated With Radiotherapy — clinical trial record (NCT04695782)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ReRad II

StatusRecruiting

PhasePhase 2

SponsorUniversity of Aarhus

StartedOct 10, 2020

View on ClinicalTrials.gov ↗

Record status

This record was last updated January 5, 2021 (before its estimated October 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

Minor Jan 4, 2021 Study First Submitted

University of Aarhus

231 trials monitored

See 5 trials at risk

Colorectal Cancer

3,394 trials monitored

See 159 trials at risk

Study design: A prospective phase II, non-randomized observational study of dose-escalated pencil beam proton therapy re-irradiation for pelvic recurrences from rectal cancer. Re-irradiation is either a part of neo-adjuvant treatment or as a definitive treatment strategy for un-resectable recurrences.

Trial Details

NCT Number	NCT04695782
Lead Sponsor	University of Aarhus
Conditions (from sponsor)	Rectal Cancer Recurrent
Enrollment	65 participants
Start Date	Oct 10, 2020
Primary Completion	Oct 31, 2025 (estimated)
Study Completion	Oct 31, 2028 (estimated)
Updated on ClinicalTrials.gov	Jan 5, 2021